| BioCyc:META_PWY-7433 |
mucin core 1 and core 2 O-glycosylation |
| BioCyc:HUMAN_PWY-7433 |
mucin core 1 and core 2 O-glycosylation |
| BioCyc:META_PWY-7435 |
mucin core 3 and core 4 O-glycosylation |
| Reactome:R-HSA-9679506 |
SARS-CoV Infections |
| Reactome:R-HSA-9683673 |
Maturation of protein 3a |
| Reactome:R-HSA-9694516 |
SARS-CoV-2 Infection |
| Reactome:R-HSA-9694635 |
Translation of Structural Proteins |
| Reactome:R-HSA-9694719 |
Maturation of protein 3a |
| Reactome:R-HSA-9678108 |
SARS-CoV-1 Infection |
| Reactome:R-HSA-9683701 |
Translation of Structural Proteins |
| Reactome:R-HSA-9772573 |
Late SARS-CoV-2 Infection Events |
| Reactome:R-HSA-9824446 |
Viral Infection Pathways |
| Reactome:R-DME-9006934 |
Signaling by Receptor Tyrosine Kinases |
| Reactome:R-HSA-190239 |
FGFR3 ligand binding and activation |
| Reactome:R-HSA-1643685 |
Disease |
| Reactome:R-MMU-162582 |
Signaling Pathways |
| Reactome:R-MMU-190236 |
Signaling by FGFR |
| Reactome:R-MMU-190372 |
FGFR3c ligand binding and activation |
| Reactome:R-DME-162582 |
Signaling Pathways |
| Reactome:R-DME-190239 |
FGFR3 ligand binding and activation |
| Reactome:R-HSA-9006934 |
Signaling by Receptor Tyrosine Kinases |
| Reactome:R-HSA-5654741 |
Signaling by FGFR3 |
| Reactome:R-DME-190372 |
FGFR3c ligand binding and activation |
| Reactome:R-MMU-9006934 |
Signaling by Receptor Tyrosine Kinases |
| Reactome:R-MMU-5654741 |
Signaling by FGFR3 |
| Reactome:R-DME-190236 |
Signaling by FGFR |
| Reactome:R-DME-5654741 |
Signaling by FGFR3 |
| Reactome:R-HSA-162582 |
Signaling Pathways |
| Reactome:R-HSA-190236 |
Signaling by FGFR |
| Reactome:R-HSA-190372 |
FGFR3c ligand binding and activation |
| Reactome:R-HSA-5663205 |
Infectious disease |
| Reactome:R-MMU-190239 |
FGFR3 ligand binding and activation |
| WikiPathways:WP5021 |
SARS-CoV-2 Infection |
| WikiPathways:WP5020 |
SARS-CoV-1 Infection |
| WikiPathways:WP4142 |
Metabolism of sphingolipids in ER and Golgi apparatus |